Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|April 16, 2017
Expression of Stem Cell Markers and Dopamine D2 Receptors in Human and Rat ProlactinomasZhichao Gao, Lin Cai, Jianglong Lu, et al.
Molecular and Cellular Endocrinology|September 18, 2020
The long noncoding RNA-H19/miRNA-93a/ATG7 axis regulates the sensitivity of pituitary adenomas to dopamine agonistsZerui Wu, Yongzhi Zheng, Wanqun Xie, et al.
The Journal of Endocrinology|November 4, 2018
MicroRNA-93 mediates cabergoline resistance by targeting ATG7 in prolactinomaZerui Wu, Lin Cai, Jianglong Lu, et al.
Biochemical and Biophysical Research Communications|September 20, 2018
RBM17 controls apoptosis and proliferation to promote Glioma progressionJianglong Lu, Qun Li, Lin Cai, et al.
Oncology Reports|August 30, 2017
HSP47 is associated with the prognosis of laryngeal squamous cell carcinoma by inhibiting cell viability and invasion and promoting apoptosisXiaoxiao Song, Zhisu Liao, Chunchun Zhou, et al.
Molecular and Cellular Endocrinology|November 5, 2013
Dopamine receptor D2S gene transfer improves the sensitivity of GH3 rat pituitary adenoma cells to bromocriptineQiang Li, Zhipeng Su, Jie Liu, et al.
Food Research International (Ottawa, Ont.)|July 6, 2026
Janus barrier films of shellac/chitosan with natamycin for photoprotective on-demand antifungal release and starch metabolism regulation in kiwifruit preservationYujiao Qian, ZiYi Chen, Zhipeng Su, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 4, 2023
EGFR-Induced and c-Src-Mediated CD47 Phosphorylation Inhibits TRIM21-Dependent Polyubiquitylation and Degradation of CD47 to Promote Tumor Immune EvasionLinyong Du, Zhipeng Su, Silu Wang, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 18, 2024
SelK promotes glioblastoma cell proliferation by inhibiting β-TrCP1 mediated ubiquitin-dependent degradation of CDK4Jizhen Li, Lingling Zhao, Zerui Wu, et al.
Cell Death & Disease|December 22, 2025
Necroptotic signaling orchestrates glioblastoma malignancy and potentiates temozolomide responseYuanyuan Li, Yuxin Qiu, Wenqing Gao, et al.
Pageof 9